Fulgent Genetics Inc Capital Reinvestment Ratio
Fulgent Genetics Inc capital reinvestment ratio. Fulgent Genetics Inc (FLGT) has a Capital Reinvestment Ratio of 0.73x as of March 2026, meaning it reinvests 1% of its operating cash flow ($7.10 Million) in capital expenditures ($5.20 Million). See Fulgent Genetics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Fulgent Genetics Inc (2016–2024)
Capital reinvestment ratio of Fulgent Genetics Inc from 2016 to 2024. This chart tracks Fulgent Genetics Inc's Capital Reinvestment Ratio across 8 annual periods. See Fulgent Genetics Inc (FLGT) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Fulgent Genetics Inc Capital Reinvestment Ratio by Year (2016–2024)
Fulgent Genetics Inc capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see FLGT cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.91x | $21.06 Million | $40.31 Million | ▲ +132.8% |
| 2023 | 0.82x | $27.00 Million | $22.21 Million | ▲ +1010.5% |
| 2022 | 0.07x | $253.52 Million | $18.77 Million | ▲ +67.3% |
| 2021 | 0.04x | $538.58 Million | $23.84 Million | ▼ -82.9% |
| 2020 | 0.26x | $140.63 Million | $36.51 Million | ▲ +21.2% |
| 2019 | 0.21x | $5.52 Million | $1.18 Million | ▼ -94.7% |
| 2017 | 4.02x | $1.33 Million | $5.36 Million | ▲ +367.9% |
| 2016 | 0.86x | $4.41 Million | $3.79 Million | — |